| FRQSC | CRISPR-Cas9 : Questions éthiques et règlementaires | Bartha Knoppers
| FRQSC | CRISPR-Cas9 : Questions éthiques et règlementaires | Bartha Knoppers
La technologie CRISPR-Cas9 ouvre de grandes perspectives pour améliorer la production végétale et animale, voire pour guérir les maladies héréditaires. Elle suscite aussi de grandes questions éthiques et juridiques, que Bartha Knoppers, directrice du Centre de génomique et politiques à l’Université McGill, présente dans cette courte vidéo.
Découvrez aussi une utilisation de CRISPR-Cas9 en santé (https://youtu.be/nsb42LNs6Uk), et en sciences naturelles et génie (https://youtu.be/Bz0aN5qEkyw) au Québec.
***
The CRISPR-Cas9 technology holds great promise for improving plant and animal production, or even to cure hereditary diseases. It also raises important ethical and legal issues that Bartha Knoppers, director of the Centre of Genomics and Policy at McGill University, presents in this short video.
Discover the use of CRISPR-Cas9 in the health sector (https://youtu.be/nsb42LNs6Uk), as well as in natural sciences and technologies (https://youtu.be/Bz0aN5qEkyw) in Québec.
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.